Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial recall — FDA D-0576-2018
Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.
Overview of recall records associated with Hospira Inc. A Pfizer Company, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.
This page summarizes recall records in which the official source identifies Hospira Inc. A Pfizer Company as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.